Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depakote and olanzapine in bipolar disorder
NCT00071253Phase 4Terminated
- Sponsor
- Abbott Laboratories
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar I disorder comparing Depakote Monotherapy, Olanzapine Monotherapy and Depakote + Olanzapine Combination (3 arms). Primary endpoints: Clinical Global Impressions-Severity, Clinical Global Impressions-Improvement and 3 more. Started Jul 2003; status: terminated.
02
Drugs
divalproex sodiumolanzapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00071253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071253.